Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
27.42
+0.31 (1.14%)
Jun 18, 2026, 3:00 PM CST
7.11% (1Y)
| Market Cap | 11.95B +27.4% |
| Revenue (ttm) | 745.32M +321.1% |
| Net Income | -919.55M |
| EPS | -2.31 |
| Shares Out | 445.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,765,296 |
| Open | 26.86 |
| Previous Close | 27.11 |
| Day's Range | 26.39 - 28.12 |
| 52-Week Range | 22.40 - 63.59 |
| Beta | 0.52 |
| Analysts | Strong Buy |
| Price Target | 38.00 (+38.59%) |
| Earnings Date | Aug 28, 2026 |